The interplay between heart failure, metabolism and body composition.
A complex interplay exists between heart failure, metabolic status and body composition. The idiosyncrasies of these relationships are poorly understood, but they offer prognostic value and potential clinical utility. Current understanding of this relationship and known clinical value are discussed in this article.
Cardiology Research Fellow in the Department of Cardiology, University Hospitals Coventry and Warwickshire NHS Trust, Coventry CV2 2DX and Translational and Experimental Medicine, University of Warwick Medical School, Coventry.
Christopher J
CJ
McAloon
Reader of Medicine in the Warwickshire Institute for the study of Diabetes, Endocrinology & Metabolism (WISDEM), University Hospitals Coventry and Warwickshire NHS Trust, Coventry and Translational and Experimental Medicine, University of Warwick Medical School, Coventry.
Paul
P
O'Hare
Consultant Cardiologist and Electrophysiologist in the Department of Cardiology, University Hospitals Coventry and Warwickshire NHS Trust, Coventry.
Faizel
F
Osman
Professor in Metabolic Medicine in the Warwickshire Institute for the study of Diabetes, Endocrinology & Metabolism (WISDEM), University Hospitals Coventry and Warwickshire NHS Trust, Coventry and Translational and Experimental Medicine, University of Warwick Medical School, Coventry.
Harpal S
HS
Randeva
D052242:Adiponectin / Q000378:metabolism*; D050154:Adiposity; D001823:Body Composition; D002100:Cachexia / Q000150:complications / Q000378:metabolism*; D006333:Heart Failure / Q000150:complications / Q000378:metabolism*; D006801:Humans; D015850:Interleukin-6 / Q000378:metabolism*; D045265:Natriuretic Peptides / Q000378:metabolism*; D011379:Prognosis; D055948:Sarcopenia / Q000150:complications / Q000378:metabolism*
D052242:Adiponectin; D015850:Interleukin-6; D045265:Natriuretic Peptides